OSOlivia Sun

Olivia Sun

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Olivia Sun has a total of 11 co-authors. Here are the top co-authors by number of shared publications:

  • Andrew Zhang

    Liver Center and Endocrine Unit, Massachusetts General Hospital, Boston, USA

    1 shared publication
  • Byungchang Jin

    Liver Center and Endocrine Unit, Massachusetts General Hospital, Boston, USA

    1 shared publication
  • Cassandra Nichole Spracklen

    Department of Biostatistics and Epidemiology, University of Massachusetts Amherst, Amherst, MA, USA

    1 shared publication
  • Charles Brenner

    Department of Diabetes and Cancer Metabolism, Beckman Research Institute, Duarte, CA, USA; Sustainable Wellbeing Across Lifespan, Faculties of Medicine and Pharmacy and the Helsinki Institute of Life Science, University of Helsinki, Helsinki, Finland

    1 shared publication
  • Edwin D. J. Lopez Gonzalez

    Beckman Research Institute of City of Hope, Duarte, USA

    1 shared publication
  • Hardik Shah

    Metabolomics Platform, Comprehensive Cancer Center, The University of Chicago, Chicago, USA

    1 shared publication

Latest Publications

  • Open Access

    Glycerol-3-phosphate activates ChREBP, FGF21 transcription and lipogenesis in citrin deficiency

    by Vinod Tiwari, Byungchang Jin, Olivia Sun, Edwin D. J. Lopez Gonzalez, Min-Hsuan Chen, Xiwei Wu, Hardik Shah, Andrew Zhang, Mark A. Herman, Cassandra N. Spracklen, et al.

    Citrin deficiency (CD) is caused by the inactivation of SLC25A13, a mitochondrial membrane protein required to move electrons from cytosolic NADH to the mitochondrial matrix in hepatocytes. People with CD do not like sweets. Here we show that SLC25A13 loss causes the accumulation of glycerol-3-phosphate (G3P), which activates the carbohydrate response element-binding protein (ChREBP) to transcribe FGF21, which acts in the brain to restrain intake of sweets and alcohol and to transcribe key genes driving lipogenesis. Mouse and human data suggest that G3P–ChREBP is a mechanistic component of the Randle Cycle that contributes to metabolic-dysfunction-associated steatotic liver disease and forms part of a system that communicates metabolic states from the liver to the brain in a manner that alters food and alcohol choices. The data provide a framework for understanding FGF21 induction in varied conditions, suggest ways to develop FGF21-inducing drugs and suggest potential drug candidates for lean metabolic-dysfunction-associated steatotic liver disease and support of urea cycle function in CD.